Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000288701 | SCV000470099 | uncertain significance | Platelet-type bleeding disorder 10 | 2016-10-27 | criteria provided, single submitter | clinical testing | The CD36 c.1181_1185dupAGCCA (p.Glu397HisfsTer8) variant results in a frameshift and is predicted to result in premature termination of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. The variant is reported at a frequency of 0.000101 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the variant frequency, disease prevalence, disease penetrance, and inheritance mode, this variant could not be ruled out of causing disease. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for platelet glycoprotein IV deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Revvity Omics, |
RCV000288701 | SCV002025118 | likely pathogenic | Platelet-type bleeding disorder 10 | 2020-12-04 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV000288701 | SCV005091074 | likely pathogenic | Platelet-type bleeding disorder 10 | 2024-01-08 | criteria provided, single submitter | clinical testing | PVS1, PM2 - The variant has been reported in ClinVar by other laboratories (Variation ID 360768) and was detected in trans with NM_001127443.1:c.1079T>G variant. |
Breakthrough Genomics, |
RCV004696039 | SCV005195611 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics Laboratory, |
RCV004696039 | SCV005197931 | pathogenic | not provided | 2023-01-16 | criteria provided, single submitter | clinical testing |